100/100 (Very Low)

OpenClaw： benign
VirusTotal： benign
StaticScan： clean

OpenClaw： benign

The skill's code, documentation, and runtime instructions are coherent with a pharmacoeconomic evaluation toolset and do not request unrelated credentials or perform suspicious I/O; minor documentatio...

[内容已截断]

VirusTotal： benign VT 报告

静态扫描： clean

No suspicious patterns detected.

README 未提供

{
    "latestVersion": {
        "_creationTime": 1773886455151,
        "_id": "k97bzy2sb2a5ycs973a7862cn1837bqv",
        "changelog": "- Updated methodological guidance to follow ISPOR Good Practices for Outcomes Research Reports.\n- Changed the recommended discount rate to 3.5%.\n- Updated the ICER willingness-to-pay threshold example to 30,000 USD, aligning with US\/UK standards and approximately 2x China's GDP per QALY.\n- Minor corrections and removed region-specific recommendations from some workflow steps for broader applicability.",
        "changelogSource": "user",
        "createdAt": 1773886455151,
        "version": "1.0.3"
    },
    "owner": {
        "_creationTime": 0,
        "_id": "publishers:missing",
        "displayName": "tlb1201",
        "handle": "tlb1201",
        "image": "https:\/\/avatars.githubusercontent.com\/u\/201767390?v=4",
        "kind": "user",
        "linkedUserId": "kn79m2vxjrdhw5zs3ax6x87ze5831fpz"
    },
    "ownerHandle": "tlb1201",
    "skill": {
        "_creationTime": 1773620087508,
        "_id": "kd76351b01mnbp0yyte5edg51x830w2r",
        "badges": [],
        "createdAt": 1773620087508,
        "displayName": "Pharmacoeconomic-evaluation",
        "latestVersionId": "k97bzy2sb2a5ycs973a7862cn1837bqv",
        "ownerUserId": "kn79m2vxjrdhw5zs3ax6x87ze5831fpz",
        "slug": "skill-pharmacoeconomic-evaluation",
        "stats": {
            "comments": 0,
            "downloads": 131,
            "installsAllTime": 0,
            "installsCurrent": 0,
            "stars": 0,
            "versions": 4
        },
        "summary": "This skill provides comprehensive guidance and tools for conducting pharmacoeconomic evaluations including cost-effectiveness analysis (CEA), cost-utility an...",
        "tags": {
            "latest": "k97bzy2sb2a5ycs973a7862cn1837bqv"
        },
        "updatedAt": 1773886609528
    }
}